Research Papers:

Identification of novel long non-coding RNAs deregulated in hepatocellular carcinoma using RNA-sequencing

Davide Degli Esposti, Hector Hernandez-Vargas, Catherine Voegele, Nora Fernandez-Jimenez, Nathalie Forey, Brigitte Bancel, Florence Le Calvez-Kelm, James McKay, Philippe Merle and Zdenko Herceg _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2016; 7:31862-31877. https://doi.org/10.18632/oncotarget.7364

Metrics: PDF 4193 views  |   HTML 5101 views  |   ?  


Davide Degli Esposti1, Hector Hernandez-Vargas1, Catherine Voegele2, Nora Fernandez-Jimenez1, Nathalie Forey2, Brigitte Bancel3,4, Florence Le Calvez-Kelm2, James McKay2, Philippe Merle3,5, Zdenko Herceg1

1Epigenetics Group, International Agency for Research on Cancer (IARC), Lyon, France

2Genetic Cancer Susceptibility Group, International Agency for Research on Cancer (IARC), Lyon, France

3Centre de Recherche en Cancérologie de Lyon, UMR INSERM 1052, CNRS 5286, Lyon Cedex, France

4Hospices Civils de Lyon, Service d’Anatomopathologie, Groupement Hospitalier Lyon Nord, Lyon, France

5Hospices Civils de Lyon, Service d’Hépatologie et de Gastroentérologie, Groupement Hospitalier Lyon Nord, Lyon, France

Correspondence to:

Zdenko Herceg, e-mail: [email protected]

Keywords: hepatocellular carcinoma, long non-coding RNA, gene networks, enhancer-associated RNAs, RNA-sequencing

Received: September 17, 2015     Accepted: January 20, 2016     Published: February 13, 2016


Functional characterization of long non-coding RNAs (lncRNAs) and their pathological relevance is still a challenging task. Abnormal expression of a few long non-coding RNAs have been found associated with hepatocellular carcinoma, with potential implications to both improve our understanding of molecular mechanism of liver carcinogenesis and to discover biomarkers for early diagnosis or therapy. However, the understanding of the global role of lncRNAs during HCC development is still in its infancy. In this study, we produced RNA-Seq data from 23 liver tissues (controls, cirrhotic and HCCs) and applied statistical and gene network analysis approaches to identify and characterize expressed lncRNAs. We detected 5,525 lncRNAs across different tissue types and identified 57 differentially expressed lncRNAs in HCC compared with adjacent non-tumour tissues using stringent criteria (FDR<0.05, Fold Change>2). Using weighted gene co-expression network analysis (WGCNA), we found that differentially expressed lncRNAs are co-expressed with genes involved in cell cycle regulation, TGF-β signalling and liver metabolism. Furthermore, we found that more than 20% of differentially expressed lncRNAs are associated to actively transcribed enhancers and that the co-expression patterns with their closest genes change dramatically during HCC development. Our study provides the most comprehensive compendium of lncRNAs expressed in HCC, as well as in control or cirrhotic livers. Our results identified both known oncogenic lncRNAs (such as H19 and CRNDE) and novel lncRNAs involved in cell cycle deregulation and liver metabolism deficits occurring during HCC development.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 7364